Plain-English translation of NCT05428358 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Pancreatic Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether magnetic resonance imaging (MRI) — an additional type of scan — can help doctors better spot liver metastases (cancer spread) in patients with pancreatic cancer. Right now, doctors use CT scans to plan surgery. This study wants to see if adding an MRI scan gives doctors more useful information to decide whether surgery is the right choice for each patient.
Pancreatic cancer is serious, and surgery can help some patients, but only if the cancer hasn't spread to the liver. Current CT scans sometimes miss small spots of cancer in the liver, which could lead to surgery that won't help. This research aims to see if the additional MRI scan catches more of these metastases so doctors can make better treatment decisions.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will receive an MRI scan of your abdomen in addition to your standard CT scan as part of your pre-surgery evaluation. The MRI will help your surgical team get a clearer picture of whether cancer has spread to your liver before they plan your operation. After surgery, the researchers will compare what the MRI showed with what they actually found during the operation to see how helpful the extra scan was.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
Denmark